The Effects of Hemocoagulase on Coagulation Factors in an Elderly Patient with Upper Gastrointestinal Hemorrhage : A Case Report
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: Hemocoagulase agkistrodon has been widely used for visceral bleeding, however, its adverse reaction has not been fully recognized.
CASE REPORT: A 65-year-old female with upper gastrointestinal hemorrhage occurred severe coagulation disorder during her hospitalization. Transfusion of blood products can not improve coagulation function. Coagulation parameters returned to normal two days after discontinuation of hemocoagulase agkistrodon.
CONCLUSION: So intravenous administration of hemocoagulase should be cautiously used for the treatment of gastrointestinal bleeding.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Current drug safety - 14(2019), 3 vom: 24., Seite 230-232 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Haiyan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Batroxobin |
|---|
| Anmerkungen: |
Date Completed 12.02.2020 Date Revised 12.02.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1574886314666190524093711 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM297426028 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM297426028 | ||
| 003 | DE-627 | ||
| 005 | 20231225091951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1574886314666190524093711 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0991.xml |
| 035 | |a (DE-627)NLM297426028 | ||
| 035 | |a (NLM)31124425 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Haiyan |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Effects of Hemocoagulase on Coagulation Factors in an Elderly Patient with Upper Gastrointestinal Hemorrhage |b A Case Report |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.02.2020 | ||
| 500 | |a Date Revised 12.02.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a BACKGROUND: Hemocoagulase agkistrodon has been widely used for visceral bleeding, however, its adverse reaction has not been fully recognized | ||
| 520 | |a CASE REPORT: A 65-year-old female with upper gastrointestinal hemorrhage occurred severe coagulation disorder during her hospitalization. Transfusion of blood products can not improve coagulation function. Coagulation parameters returned to normal two days after discontinuation of hemocoagulase agkistrodon | ||
| 520 | |a CONCLUSION: So intravenous administration of hemocoagulase should be cautiously used for the treatment of gastrointestinal bleeding | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Coagulationdisorder | |
| 650 | 4 | |a Hemocoagulase agkistrodon | |
| 650 | 4 | |a enzymes | |
| 650 | 4 | |a fibrinopeptide | |
| 650 | 4 | |a gastrointestinal hemorrhage | |
| 650 | 4 | |a hypofibrinogenemia. | |
| 650 | 7 | |a Blood Coagulation Factors |2 NLM | |
| 650 | 7 | |a Batroxobin |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug safety |d 2006 |g 14(2019), 3 vom: 24., Seite 230-232 |w (DE-627)NLM181475790 |x 2212-3911 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2019 |g number:3 |g day:24 |g pages:230-232 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1574886314666190524093711 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2019 |e 3 |b 24 |h 230-232 | ||